Register now for the 2nd webinar in the 2021 CORD Consultations on the Pan-Canadian Rare Drug Framework.
January 29, 2021, at 11am EST.
How Other Countries Provide Access to Rare Disease Drugs: What Canada can Learn … or Not
This week is a MAJOR information dump from Canada’s leading expert on international approaches to Rare Disease Drug Access.
Similar but not Same: France, Germany, UK, Italy and Spain
Who Does it Best for Patients with HPP, XLH, MPS IV, SMA, and CF?
Value of A Rare Drug: What is Right “ICER” … or Does It Matter?
Whither EDRD Supplemental Process … or Does It Matter?
Principles for Rare Drug Framework/Program/Strategy
Keynote Speaker: Dr. Tania Stafinski, PRISM (Promoting Rare Disease Innovations Through Sustainable Mechanisms)